Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pluristem Therapeutics (PSTI)
NASDAQ:PSTI
Holding PSTI?
Track your performance easily
See the Price Targets and Ratings of:
PSTI Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PSTI Stock 12 Month Forecast
Average Price Target
$7.00
▲(600.00% Upside)
| Highest Price Target$10.00 | Average Price Target$7.00 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
PSTI Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
PSTI Financial Forecast
PSTI Stock Forecast FAQ
What is PSTI’s average 12-month price target, according to analysts?
Based on analyst ratings, Pluristem Therapeutics’s 12-month average price target is $7.00.
What is PSTI’s upside potential, based on the analysts’ average price target?
Pluristem Therapeutics has 600.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PSTI a Buy, Sell or Hold?
Pluristem Therapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Pluristem Therapeutics’s price target?
The average price target for Pluristem Therapeutics is $7.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $4.00. The average price target represents 600.00% Increase from the current price of $1.
The highest analyst price target is $10.00 ,the lowest forecast is $4.00. The average price target represents 600.00% Increase from the current price of $1.
What do analysts say about Pluristem Therapeutics?
Pluristem Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of PSTI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.